Non-erythroid effects of erythropoietin: are neutrophils a target?

Leuk Res. 2009 Oct;33(10):1430-2. doi: 10.1016/j.leukres.2009.03.020. Epub 2009 Apr 18.

Abstract

We have previously shown that erythropoietin (EPO) potentiates the immune response. Analysis of various possible cellular mediators was performed on EPO-injected mice and transgenic mice overexpressing human EPO (tg6). Here we present our studies on neutrophils, peritoneal (casein induced), and from the peripheral blood, spleen and bone marrow. Neutrophil counts were elevated in peripheral blood and spleens of the tg6 mice, yet, no other EPO-associated effects were detected in the count and function of the different neutrophil populations. Hence, neutrophils are probably not mediators of the EPO immunological effects, although their counts may be affected by extreme EPO levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / physiology
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Epoetin Alfa
  • Erythropoietin / genetics
  • Erythropoietin / pharmacology*
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Reactive Oxygen Species / metabolism
  • Recombinant Proteins

Substances

  • Reactive Oxygen Species
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa